Vmbook Online ordering

Icons

**Company Information**

**Name:** ICON plc

**Symbol:** USB

**Exchange:** Nasdaq Global Select Market

**USB Symbol**

The USB symbol represents the company's name, ICON plc. The company provides clinical research services to pharmaceutical, biotechnology, and medical device companies.

**Earnings and Growth**

**Recent Earnings:**

* Q3 2023: Revenue of $1.19 billion, up 13.5% year-over-year

* Net income of $106.2 million, up 21.7% year-over-year

**Growth Metrics:**

* Revenue growth rate (5-year): 14.5%

* Net income growth rate (5-year): 18.3%

* Earnings per share (EPS) growth rate (5-year): 17.6%

**Other Key Metrics:**

* Market capitalization: $10.7 billion

* Number of employees: 17,000+

* Global presence: 185+ countries

**Industry and Competitors**

ICON plc operates in the clinical research services industry. Key competitors include:

* PPD

* Covance

* PRA Health Sciences

* QuintilesIMS

**Investment Considerations**

* **Strong financial performance:** ICON has consistently reported revenue and earnings growth.

* **Growing demand for clinical research services:** The pharmaceutical industry is increasingly outsourcing clinical trials to specialized companies.

* **Global reach:** ICON has a presence in over 185 countries, providing access to a wide range of patient populations.

* **Innovation:** ICON invests in technology and data analytics to improve efficiency and accuracy in clinical trials.

* **Risks:** Competition in the industry is intense, and ICON faces regulatory and compliance challenges.